Updated overall survival and PD-L1 subgroup analysis of patients with extensive-stage small-cell lung cancer treated with atezolizumab, carboplatin, and etoposide (IMpower133) - Liu, S V; Reck, M; Mansfield, A S (J Clin Oncol, 2021)